Arxis, Inc. is a US-listed company in the aerospace & defense industry. Its financial year ends in December.
Stock price today
Loading chart…
Third-party market data · may be delayed
Model estimate per share
~$33
Forward price-to-earnings vs peers
Base case. Range ~$27–$45. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.
Price vs value
No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.
Arxis, Inc. valuation: adjust assumptions and compare models →
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Insiders7 buying, 0 selling7 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
- Funds133 adding, 0 cuttingOf 47 active managers that changed their stake, 47 added; quarter to June 30, 2026Fund buyers and sellers
The Fundamentalytics view
Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 29% in the quarter to 2026-09-30, the 2nd beat in the last four quarters.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
- Estimates rising. Analysts' consensus for next year's earnings per share has risen 14.7% over 90 days.
Things to watch
- Volatile shares. Over the past year the shares showed annualised volatility of 62% and a beta of 1.9 against the S&P 500.
- Short interest rising. Shares sold short rose 60% in a month to 6.5% of tradable shares.
Latest results
- Earnings per share
- $0.37 against an average estimate of $0.29: beat by 29.1%
- Share reaction
- +11.2% in the first session after the results on July 29, 2026, against +0.1% for the S&P 500
- Guidance given
- revenue $1,960m to $1,980m (Full-Year 2026); adjusted EBITDA $790m to $800m (Full-Year 2026)
- Next report
- January 27, 2027; average EPS estimate $0.28
Price chart
- 1 day+3.2%
- 1 week-0.6%
- 1 month+4.6%
Loading chart…
Third-party market data · may be delayed
At a glance
Earnings
- Last results
- July 29, 2026
News & updates
Company announcements, filed results and changes that matter to shareholders.
- ResultsCompany announcement headlineRead source ↗
- Deal
Arxis, Inc. completed an acquisition or disposal; sold unregistered shares
SEC 8-KRead source ↗ - Results
Arxis, Inc. reported results
SEC 8-KRead source ↗ - Guidance
Guidance issued: revenue of $1,960.00m to $1,980.00m for the Full-Year 2026
The company also guided to adjusted ebitda of $790.00m to $800.00m for the Full-Year 2026.
Company results release
Valuation models
We value Arxis, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.2%: the 10-year Treasury yield (4.9%) plus a beta of 1.16 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$7.4 ~$4.1–$10 | Left out: out of range vs price (0.15x) |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$33 ~$27–$45 | Included |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. | — 0 | Does not apply: no positive value |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$33 ~$27–$45 | 1 model |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Arxis, Inc. with Aerospace & Defense in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Forecasts and guidance
Next results: January 27, 2027, after the close. Analysts expect revenue of $546m and EPS of $0.28 (range $0.22 to $0.35) for the quarter.
Analysts' consensus
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $1.08 | — | $2.1bn | +30% |
| Next | $1.38 | +28% | $2.5bn | +19% |
Next year's EPS estimate has moved +14.7% in 90 days, across 9 analysts.
How the EPS forecast has moved
The consensus EPS forecast for the current fiscal year is +5.9% on 90 days ago. In the last 30 days, 0 analysts raised Arxis, Inc.'s forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
View chart data
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $1.02 | $1.21 |
| 60 days ago | $1.02 | $1.34 |
| 30 days ago | $1.01 | $1.29 |
| 7 days ago | $1.02 | $1.32 |
| Now | $1.08 | $1.38 |
Earnings against estimates
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $0.29 | $0.37 | +29.1% |
| Jun 2026 | $0.19 | $0.28 | +48.9% |
Adjusted EPS as companies report it, against the average analyst estimate.
Positioning
- Short interest
- 6.5% of tradable shares
- Days to cover
- 4.61 at average volume
- Short interest, 1 month
- +60% to October 15, 2026
- Held by institutions
- 67% of shares
- Held by insiders
- 13.6% of shares
- Employees
- 5,753 full time
Share-price performance
Market data may be delayedPrice behaviour
- 52-week range
- Not enough history
- From 52-week high
- —
- vs 50-day average
- −1.0%
- vs 200-day average
- —
- Volatility (1 year)
- 62%
- Beta vs S&P 500
- 1.86
Share price after results
- Next day
- 2 up, 0 down typical move ±12.1%
- After a week
- 2 up, 0 down typical move ±20.4%
- After a month
- 2 up, 0 down typical move ±19.1%
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| July 29, 2026 | +11.2% | +0.1% | +35.3% | +22.6% |
| May 28, 2026 | +13.0% | +0.8% | +5.6% | +15.7% |
Fundamentals
Financial health
- Short-term assets cover short-term liabilities $1.3bn of assets due within a year against $284m of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.3bn short-term assets against $2.4bn of longer-dated liabilities.
- More cash than debt $494m of cash against $1.7bn of debt.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Who owns it
Funds buying and selling- Reported value
- $2.7B
- Institutions reporting
- 139
- Positions opened / closed
- 133 / 0
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | $237M | 5.1M | 8.7% | — |
| Jupiter Topco LLC | $208M | 4.5M | 7.6% | — |
| Capital International Investors | $166M | 3.6M | 6.1% | — |
| Capital Research Global Investors | $166M | 3.6M | 6.1% | — |
| Price T Rowe Associates Inc | $143M | 3.1M | 5.2% | — |
| Ameriprise Financial Inc | $123M | 2.7M | 4.5% | — |
| Blackrock, Inc. | $101M | 2.2M | 3.7% | — |
| Vanguard Capital Management LLC | $86M | 1.9M | 3.1% | — |
| Invesco Ltd. | $84.6M | 1.8M | 3.1% | — |
| Citadel Advisors LLC | $74.2M | 1.6M | 2.7% | — |
| Massachusetts Financial Services Co | $72.8M | 1.5M | 2.7% | — |
| Vanguard Portfolio Management LLC | $69.2M | 1.5M | 2.5% | — |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Arxis, Inc.'s complete shareholder register. Values are as reported by the filers .
Insider trading activity
Full insider history and chart| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Roth Jason Aaron See Remarks | April 17, 2026 | Buy | 60,000 | $28.00 | $1.7M |
| Perhamus Kevin Scott See Remarks | April 17, 2026 | Buy | 53,600 | $28.00 | $1.5M |
| Allen Patrick E Director | April 17, 2026 | Buy | 10,000 | $28.00 | $280,000 |
| Oetgen Stephen Duane Director | April 17, 2026 | Buy | 25,000 | $28.00 | $700,000 |
| Sealfon Ross Bradley See Remarks | April 17, 2026 | Buy | 12,500 | $28.00 | $350,000 |
| Badakhsh Azad Sid See Remarks | April 17, 2026 | Buy | 36,000 | $28.00 | $1M |
| Jankowski Ryan Anthony Chief Accounting Officer | April 17, 2026 | Buy | 4,464 | $28.00 | $124,992 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
- July 29, 2026
- May 28, 2026
Recent SEC filings
- 10-Q Quarterly report
- 8-K Current report
- S-1 S-1
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Arxis, Inc. in brief
- What does Arxis, Inc. do?
- Arxis, Inc. is a US-listed company in the aerospace & defense industry. Its financial year ends in December.
- What is Arxis, Inc.'s stock ticker?
- Arxis, Inc. trades under the ticker ARXS on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
- Who are Arxis, Inc.'s largest institutional shareholders?
- By value reported in 13F filings for June 30, 2026, the largest reported holders are T. Rowe Price Investment Management, Inc., Jupiter Topco LLC and Capital International Investors. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
- Are insiders buying or selling Arxis, Inc. stock?
- Over the last 12 months, Arxis, Inc.'s directors and officers reported 7 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
- When is Arxis, Inc.'s next earnings date?
- Around January 27, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Arxis, Inc. announces its own schedule.
Follow research on Arxis, Inc.
New research on the companies we cover arrives in the weekly email. Free, one email a week.